We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.3%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$31.7B
AUM Growth
-$2.67B
Cap. Flow
-$2.89B
Cap. Flow %
-9.11%
Top 10 Hldgs %
5.56%
Holding
3,128
New
137
Increased
922
Reduced
1,808
Closed
223

Sector Composition

Rank Sector Weight
1 Technology 12.05%
2 Healthcare 11.54%
3 Consumer Discretionary 10.85%
4 Financials 10.67%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
2726
Tandem Diabetes Care
TNDM
$1.29B
$148K ﹤0.01%
1,708
+2
+0.1% +$175
RLOG
2727
DELISTED
Rand Logistics, Inc.
RLOG
$147K ﹤0.01%
154,628
-2,391
-2% -$2.52K
ZAGG
2728
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$144K ﹤0.01%
+15,929
New +$152K
TMHC
2729
DELISTED
Taylor Morrison
TMHC
$143K ﹤0.01%
10,153
-14,129
-58% -$187K
TAC icon
2730
TransAlta
TAC
$3.95B
$140K ﹤0.01%
29,966
-10,896
-27% -$42.2K
BGY icon
2731
BlackRock Enhanced International Dividend Trust
BGY
$526M
$138K ﹤0.01%
23,428
-12,578
-35% -$71.7K
BPFH
2732
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$138K ﹤0.01%
12,077
-2,553
-17% -$27K
BHL
2733
DELISTED
Blackrock Defined Opp Crt Tr
BHL
$137K ﹤0.01%
+10,482
New +$135K
LIOX
2734
DELISTED
Lionbridge Technologies
LIOX
$136K ﹤0.01%
26,916
-11,827
-31% -$53.9K
COHU icon
2735
Cohu
COHU
$2.45B
$132K ﹤0.01%
+11,073
New +$129K
CORT icon
2736
Corcept Therapeutics
CORT
$11.7B
$132K ﹤0.01%
+28,290
New +$110K
ACLS icon
2737
Axcelis
ACLS
$4.2B
$131K ﹤0.01%
11,710
-31
-0.3% -$317
FTF
2738
Franklin Limited Duration Income Trust
FTF
$232M
$130K ﹤0.01%
11,448
DSU icon
2739
BlackRock Debt Strategies Fund
DSU
$593M
$129K ﹤0.01%
12,423
-15,714
-56% -$156K
HHS icon
2740
Harte-Hanks
HHS
$16.9M
$129K ﹤0.01%
5,050
-643
-11% -$19.8K
KNDI
2741
Kandi Technologies Group
KNDI
$70.3M
$129K ﹤0.01%
17,868
-1,894
-10% -$14.7K
KEF
2742
DELISTED
Korea Equity Fund
KEF
$129K ﹤0.01%
16,086
BLDR icon
2743
Builders FirstSource
BLDR
$7.8B
$128K ﹤0.01%
11,338
-18,390
-62% -$159K
MCEP
2744
DELISTED
Mid-Con Energy Partners, LP
MCEP
$127K ﹤0.01%
3,583
-2,100
-37% -$49.2K
CLDX icon
2745
Celldex Therapeutics
CLDX
$3.26B
$123K ﹤0.01%
2,162
-18,346
-89% -$2.06M
FOF icon
2746
Cohen & Steers Closed End Opportunity Fund
FOF
$377M
$123K ﹤0.01%
11,276
GOGO icon
2747
Gogo Inc
GOGO
$492M
$120K ﹤0.01%
10,931
-9,945
-48% -$126K
PCY icon
2748
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
$120K ﹤0.01%
4,233
+4,120
+3,646% +$113K
KZ
2749
DELISTED
KongZhong Corporation
KZ
$118K ﹤0.01%
16,485
-589
-3% -$4.24K
SALE
2750
DELISTED
RetailMeNot, Inc. Series 1
SALE
$117K ﹤0.01%
+14,605
New +$119K

Similar funds

Guggenheim Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Guggenheim Capital held 3,128 positions worth $31.7B, down 7.8% from $34.4B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Guggenheim Capital withdrew a net $2.89B in Q1 2016, closing 223 positions and reducing 1,808 holdings. Its most notable exit was KEURIG GREEN MTN INC, an estimated $41.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Guggenheim Capital opened a new position in Enovis worth $6.52M.

  • Guggenheim Capital's largest Q1 2016 buy was Enovis: 132,562 shares worth $6.52M.
  • Guggenheim Capital added most to State Street SPDR Bloomberg High Yield Bond ETF in Q1 2016, an estimated $62.9M increase.
  • Guggenheim Capital's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $47.1M.
  • Guggenheim Capital fully exited KEURIG GREEN MTN INC in Q1 2016, selling an estimated $41.7M.
  • Guggenheim Capital's ten largest holdings make up 5.6% of its $31.7B portfolio in Q1 2016.
  • Guggenheim Capital opened 137 new positions and closed 223 in Q1 2016.
  • Guggenheim Capital's portfolio value fell 7.8% quarter-over-quarter to $31.7B.

Based on Guggenheim Capital's 13F filing for Q1 2016, filed 16 May 2016.